Aureobasidium.org

In Vitro 2017

Aureobasidium pullulans produced β-glucan is effective to enhance Kurosengoku soybean extract induced Thrombospondin-1 expression

Muramatsu, Daisuke; Okabe, Mitsuyasu; Takaoka, Akinori; Kida, Hiroshi; Iwai, Atsushi · Scientific Reports · DOI: 10.1038/s41598-017-03053-9 · PMID: 28588201
Research Archive
TL;DR — Key Findings
  • A soybean-derived preparation and A. pullulans beta-glucan were tested in cultured Mono Mac 6 cells.
  • The combination increased thrombospondin-1 expression more than soybean extract alone.
  • The study did not demonstrate tumor inhibition, anti-angiogenesis, or human benefit.

Abstract

This cell-culture study examined Aureobasidium pullulans cultured fluid produced with Kurosengoku soybean and containing beta-glucan. In Mono Mac 6 cells, the preparation increased expression of thrombospondin-1. Combining beta-glucan with Kurosengoku soybean extract produced a larger expression response than soybean extract alone, which the authors interpreted as a synergistic effect. The experiment measured gene or protein expression in a cultured human monocyte-derived cell line. It did not test tumor growth, blood-vessel formation, cancer treatment, or outcomes in animals or people.

Summary

Summary

Study design

Mono Mac 6 cells were exposed to Kurosengoku soybean extract, A. pullulans beta-glucan, or their combination.

Interpretation

The combination increased thrombospondin-1 expression in vitro. Anticancer or anti-angiogenic effects were not directly tested.

AI-generated summary for accessibility. Always refer to the original paper.

Keywords

thrombospondin-1 TSP-1 anti-angiogenesis beta glucan Aureobasidium pullulans Kurosengoku soybean synergy cancer tumor vascularization angiogenesis inhibition

Citation

Muramatsu, Daisuke; Okabe, Mitsuyasu; Takaoka, Akinori; Kida, Hiroshi; Iwai, Atsushi. Aureobasidium pullulans produced β-glucan is effective to enhance Kurosengoku soybean extract induced Thrombospondin-1 expression. Scientific Reports. 2017. DOI: 10.1038/s41598-017-03053-9. PMID: 28588201.

Study Details
Study Type
In Vitro
Published
2017
Journal
Scientific Reports
Authors
Muramatsu, Daisuke; Okabe, Mitsuyasu; Takaoka, Akinori; Kida, Hiroshi; Iwai, Atsushi
PubMed ID
28588201
Important Notice

For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.